A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

Cenksoy C., Cenksoy P. O., ERDEM O. A., Sancak B., Gursoy R.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.174, ss.86-90, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 174
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.ejogrb.2013.12.001
  • Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.86-90
  • Anahtar Kelimeler: OHSS, Prevention, VEGF, V1a receptor antagonist, Relcovaptan, ENDOTHELIAL GROWTH-FACTOR, SMOOTH-MUSCLE-CELLS, HORMONE AGONIST, CAPILLARY-PERMEABILITY, VASCULAR-PERMEABILITY, MOLECULAR-CLONING, EXPRESSION, RECEPTOR, PREVENTION, RISK
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: To investigate the effects of VIA receptor antagonist through inhibition of vasopressin-induced, VEGF secretion in an experimental model.